Annette Bryant - Concepedia

Concepedia

Author

Annette Bryant

Royal Marsden Hospital ORCID

Also Known As

A BRYANT, A Bryant, A E BRYANT, A E Bryant, A. Bryant, ANNETTE BRYANT, Annette Bryant, Annette E. Bryant, Bryant, Annette

83

Publications

1.7K

Citations

19

H-Index

59

Concepts

All Affiliations

Royal Marsden Hospital Royal Marsden NHS Foundation Trust Institute of Cancer Research University College London MRC Clinical Trials Unit at UCL

AB

About

Annette Bryant is an author at Royal Marsden Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	951
2	Allergy	5	5	161
3	Health Sciences	4	4	104
4	Cell Biology	2	2	246
5	Education	1	1	13

Annette Bryant

×

25

Publications

1.7K

Citations

19

H-Index

	Year	Citations
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer Andrew Woolston, Khurum Khan, Georgia Spain, Cancer Cell Tumor BiologyCetuximab Resistance LandscapeImmune Landscape EvolutionColorectal CancersMedicine	2019	254
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial Khurum Khan, David Cunningham, Benjamin Werner, Cancer Discovery	2018	233
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Stella C. Knight, J. Farrant, Annette Bryant, PubMed InflammationLow-density CellsGranulocyteMedicineImmunology	1986	210
Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2 Annette Bryant, N.C Calver, Elias Toubi, Clinical Immunology and Immunopathology Primary ImmunodeficiencyAutoimmune DiseaseImmunodeficienciesB Cell SecretionImmunology	1990	169
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct Sheela Rao, Francesco Sclafani, Cathy Eng, Journal of Clinical Oncology	2020	140
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids Reyes Gonzalez-Exposito, Maria Semiannikova, B Griffiths, Journal for ImmunoTherapy of Cancer	2019	110
Induction of autoimmunity with dendritic cells: Studies on thyroiditis in mice Stella C. Knight, J. Farrant, John Chan, Clinical Immunology and Immunopathology InflammationAutoimmune DiseaseAllergyImmune RegulationImmunology	1988	65
Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry Erkan Demirkaya, Celal Sağlam, Türker Türker, The Journal of Rheumatology	2015	59
Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. J. Farrant, Annette Bryant, A. M. L. Lever, PubMed ImmunohematologyLow Immunoglobulin ProductionImmunologyBlood CellPathology	1985	51
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial Gayathri Anandappa, Andrea Lampis, David Cunningham, Clinical Cancer Research	2019	45

Page 1